[1] |
陈丽洁, 梁景耀, 刘玉梅, 等. 特应性皮炎转录组学及靶点治疗研究进展[J]. 中华皮肤科杂志, 2018,51(2):157⁃159. doi: 10.3760/cma.j.issn.0412⁃4030.2018.02.025.
|
[2] |
Lauffer F, Ring J. Target⁃oriented therapy: emerging drugs for atopic dermatitis[J]. Expert Opin Emerg Drugs, 2016,21(1):81⁃89. doi: 10.1517/14728214.2016.1146681.
|
[3] |
Andersen L, Nyeland ME, Nyberg F. Increasing severity of atopic dermatitis is associated with a negative impact on work productivityamong adults with atopic dermatitis in France, Germany, the UK and the US[J/OL]. Br J Dermatol, 2019. [2019⁃07⁃08]. https://sci⁃hub.tw/10.1111/bjd.18296. doi: 10.1111/bjd.18296. [published online ahead of print Jul 1, 2019]
|
[4] |
Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA⁃seq data with DESeq2[J]. Genome Biol, 2014,15(12):550. doi: 10.1186/s13059⁃014⁃0550⁃8.
|
[5] |
Audic S, Claverie JM. The significance of digital gene expression profiles[J]. Genome Res, 1997,7(10):986⁃995. doi: 10.1101/gr. 7.10.986.
|
[6] |
Parks DH, Beiko RG. Identifying biologically relevant differences between metagenomic communities[J]. Bioinformatics, 2010,26(6):715⁃721. doi: 10.1093/bioinformatics/btq041.
|
[7] |
Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency[J]. Ann Stat, 2001,29(4):1165⁃1188. doi: 10.1214/aos/1013699998.
|
[8] |
Wang C, Gong B, Bushel PR, et al. The concordance between RNA⁃seq and microarray data depends on chemical treatment and transcript abundance[J]. Nat Biotechnol, 2014,32(9):926⁃932. doi: 10.1038/nbt.3001.
|
[9] |
Noda S, Suárez⁃Fariñas M, Ungar B, et al. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization[J]. J Allergy Clin Immunol, 2015,136(5):1254⁃1264. doi: 10.1016/j.jaci.2015.08. 015.
|
[10] |
Guttman⁃Yassky E, Krueger JG. IL⁃17C: unique epithelial cytokine with potential for targeting across the spectrum of atopic dermatitis and psoriasis[J]. J Invest Dermatol, 2018,138(7):1467⁃1469. doi: 10.1016/j.jid.2018.02.037.
|
[11] |
Ramirez⁃Carrozzi V, Sambandam A, Luis E, et al. IL⁃17C regulates the innate immune function of epithelial cells in an autocrine manner[J]. Nat Immunol, 2011,12(12):1159⁃1166. doi: 10.1038/ni.2156.
|
[12] |
Li R, Hadi S, Guttman⁃Yassky E. Current and emerging biologic and small molecule therapies for atopic dermatitis[J]. Expert Opin Biol Ther, 2019,19(4):367⁃380. doi: 10.1080/14712598. 2019.1573422.
|
[13] |
Sanyal RD, Pavel AB, Glickman J, et al. Atopic dermatitis in African American patients is TH2/TH22⁃skewed with TH1/TH17 attenuation[J]. Ann Allergy Asthma Immunol, 2019,122(1):99⁃110.e6. doi: 10.1016/j.anai.2018.08.024.
|
[14] |
Suárez⁃Fariñas M, Ungar B, Correa dRJ, et al. RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications[J]. J Allergy Clin Immunol, 2015,135(5):1218⁃1227. doi: 10. 1016/j.jaci.2015.03.003.
|
[15] |
Jung Y, Kim JC, Park NJ, et al. Eupatilin, an activator of PPARα, inhibits the development of oxazolone⁃induced atopic dermatitis symptoms in Balb/c mice[J]. Biochem Biophys Res Commun, 2018,496(2):508⁃514. doi: 10.1016/j.bbrc.2018.01. 098.
|
[16] |
Khattri S, Brunner PM, Garcet S, et al. Efficacy and safety of ustekinumab treatment in adults with moderate⁃to⁃severe atopic dermatitis[J]. Exp Dermatol, 2017,26(1):28⁃35. doi: 10.1111/exd.13112.
|
[17] |
Paplińska⁃Goryca M, Nejman⁃Gryz P, Górska K, et al. Expression of inflammatory mediators in induced sputum: comparative study in asthma and COPD[J]. Adv Exp Med Biol, 2018,1040:101⁃112. doi: 10.1007/5584_2016_165.
|
[18] |
Pothoven KL, Norton JE, Suh LA, et al. Neutrophils are a major source of the epithelial barrier disrupting cytokine oncostatin M in patients with mucosal airways disease[J]. J Allergy Clin Immunol, 2017,139(6):1966⁃1978.e9. doi: 10.1016/j.jaci.2016. 10.039.
|
[19] |
Queiroz GA, Costa RS, Alcantara⁃Neves NM, et al. IL33 and IL1RL1 variants are associated with asthma and atopy in a Brazilian population[J]. Int J Immunogenet, 2017,44(2):51⁃61. doi: 10.1111/iji.12306.
|
[20] |
Sivaprasad U, Kinker KG, Ericksen MB, et al. SERPINB3/B4 contributes to early inflammation and barrier dysfunction in an experimental murine model of atopic dermatitis[J]. J Invest Dermatol, 2015,135(1):160⁃169. doi: 10.1038/jid.2014.353.
|
[21] |
Ghosh D, Ding L, Sivaprasad U, et al. Multiple transcriptome data analysis reveals biologically relevant atopic dermatitis signature genes and pathways[J/OL]. PLoS One, 2015,10(12):e0144316. doi: 10.1371/journal.pone.0144316.
|
[22] |
Cornelissen C, Marquardt Y, Czaja K, et al. IL⁃31 regulates differentiation and filaggrin expression in human organotypic skin models[J]. J Allergy Clin Immunol, 2012,129(2):426⁃433, 433.e1⁃8. doi: 10.1016/j.jaci.2011.10.042.
|